Uncertainty about postmenopausal estrogen. Time for action, not debate.

The debate about p-values.

A debate about moral enhancement.

Enhancing debate about the sexes.

Talk is not enough--now it is time for action.

Estrogen therapy in postmenopausal women.

Estrogen therapy in postmenopausal women.

Postmenopausal estrogen and prevention bias.

Data, not debate!

Estrogen replacement in postmenopausal disorders.

Pressure on staff prompts debate about charging for primary care.

Addiction and the American debate about homelessness.

The great healthcare debate: for-profit vs. not-for-profit.

Acknowledging uncertainty about maternal mortality estimates.

Transdermal estrogen replacement does not increase calcitonin secretory reserve in postmenopausal women.

Risks and benefits of postmenopausal exogenous estrogen.

Treatment of postmenopausal osteoporosis with transdermal estrogen.

Postmenopausal estrogen therapy and cardiovascular disease.

Gain-of-function experiments: time for a real debate.

Selective preparation and time uncertainty.

Letters to the editor: time for more scholarly debate.

Electronic cigarettes: time for an accurate and evidence-based debate.

Indigenous health: time for action.

Indigenous health: time for action.

Undiagnosed MODY: Time for Action.

Suggest Documents

The debate about p-values.

A debate about moral enhancement.

Enhancing debate about the sexes.

Talk is not enough--now it is time for action.

Estrogen therapy in postmenopausal women.

Estrogen therapy in postmenopausal women.

Postmenopausal estrogen and prevention bias.

Data, not debate!

Estrogen replacement in postmenopausal disorders.

Pressure on staff prompts debate about charging for primary care.

Addiction and the American debate about homelessness.

The great healthcare debate: for-profit vs. not-for-profit.

Acknowledging uncertainty about maternal mortality estimates.

Transdermal estrogen replacement does not increase calcitonin secretory reserve in postmenopausal women.

Risks and benefits of postmenopausal exogenous estrogen.

Treatment of postmenopausal osteoporosis with transdermal estrogen.

Postmenopausal estrogen therapy and cardiovascular disease.

Gain-of-function experiments: time for a real debate.

Selective preparation and time uncertainty.

Letters to the editor: time for more scholarly debate.

Electronic cigarettes: time for an accurate and evidence-based debate.

Indigenous health: time for action.

Indigenous health: time for action.

Undiagnosed MODY: Time for Action.

Uncertainty about postmenopausal estrogen. Time for action, not debate.

Recommend Documents

Follow Us